Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 diabetes.
about
Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiencyAntiobesity pharmacotherapy: new drugs and emerging targetsNew advances in models and strategies for developing anti-obesity drugs.Obesity pharmacotherapy: what is next?The evolving place of incretin-based therapies in type 2 diabetesDefining the pathway to insulin-like growth factor system targeting in cancer.Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.Management of diabetes across the course of disease: minimizing obesity-associated complicationsPresent and Prospective Pharmacotherapy for the Management of Patients with Type 2 DiabetesImpact of GLP-1 receptor agonists on major gastrointestinal disorders for type 2 diabetes mellitus: a mixed treatment comparison meta-analysisMedicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus.
P2860
Q28740948-8BC66297-C632-4DA9-9571-BD2E5048E00BQ30354242-F315F68D-ADE2-489F-8D05-FBFDC1EA2D3DQ30429816-65554A6A-7B4E-4539-A1EE-20C0ABC600B3Q33827988-AB60741D-2BA5-4A16-AE4F-6377ECA2BB79Q33866808-4DAE7314-E327-4B05-A15E-EEDF931D9953Q34107722-07369ED7-AEFC-4CB3-85B5-67A2983B6261Q34915090-55DF06CC-8828-46A9-B7A3-4A8540D3CEFBQ35574560-ED33B8EB-856B-45E6-B41F-6AF7816A59F3Q35909303-85ADA7E9-18A8-4491-AC59-1D8DF8AF8640Q36520655-8B2BC4B2-061F-47F8-85C3-B6D1AD83D01DQ37941683-F14AC4DB-93B0-43EE-8992-00B53D0A0507
P2860
Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Overview of glucagon-like pept ...... nhibitors for type 2 diabetes.
@en
Overview of glucagon-like pept ...... nhibitors for type 2 diabetes.
@nl
type
label
Overview of glucagon-like pept ...... nhibitors for type 2 diabetes.
@en
Overview of glucagon-like pept ...... nhibitors for type 2 diabetes.
@nl
prefLabel
Overview of glucagon-like pept ...... nhibitors for type 2 diabetes.
@en
Overview of glucagon-like pept ...... nhibitors for type 2 diabetes.
@nl
P31
P1476
Overview of glucagon-like pept ...... inhibitors for type 2 diabetes
@en
P2093
Richard E Pratley
P577
2008-07-28T00:00:00Z